Recently, the SFDA released a draft for discussion indicating its intention to streamline generic drug pricing. The draft pointed out that the SFDA will grant the first-to-market generic drug the...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)
+65 6592-6978